Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds

被引:22
作者
Bosch, S. [1 ]
Bot, R. [1 ]
Wicaksono, A. [2 ]
Savelkoul, E. [1 ]
van der Hulst, R. [3 ,4 ]
Kuijvenhoven, J. [3 ,4 ]
Stokkers, P. [5 ]
Daulton, E. [2 ]
Covington, J. A. [2 ]
de Meij, T. G. J. [6 ]
de Boer, N. K. H. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam UMC, AG&M Res Inst, Amsterdam, Netherlands
[2] Univ Warwick, Sch Engn, Coventry, W Midlands, England
[3] Spaarne Gasthuis, Dept Gastroenterol & Hepatol, Hoofddorp, Netherlands
[4] Spaarne Gasthuis, Dept Gastroenterol & Hepatol, Haarlem, Netherlands
[5] OLVG West, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[6] Amsterdam UMC, Dept Paediat Gastroenterol, Amsterdam, Netherlands
关键词
Volatile organic compounds; eNose; colorectal cancer; advanced adenoma; screening; surveillance; SURVEILLANCE; GUIDELINES; ADENOMAS; UPDATE; COSTS;
D O I
10.1111/codi.15009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Early detection and removal of colorectal cancer (CRC) and advanced adenomas (AAs) decreases the incidence of and mortality from the disease. We aimed to evaluate the potential of faecal volatile organic compounds (VOCs) for detection and follow-up of colorectal adenoma using advanced electronic nose technology. Method This was a prospective multi-centre case-control cohort including two district hospitals and one tertiary referral hospital. Patients undergoing colonoscopy were instructed to collect a faecal sample prior to bowel cleansing and were included in the study when CRC, AAs, large adenomas (LAs; 0.5-1.0 cm), small adenomas (SAs; 0.1-0.5 cm) or no endoscopic abnormalities (controls) were observed. Patients undergoing polypectomy and controls were asked for a second sample after 3 months. Faecal VOCs were measured with gas chromatography-ion mobility spectrometry. Random forest, support vector machine, Gaussian process and neural net classification were used to evaluate accuracy. Results In total, 14 patients with CRC, 64 with AAs, 69 with LAs, 127 with SAs and 227 controls were included. A second sample was collected from 32 polypectomy patients and 32 controls. Faecal VOCs discriminated CRC and adenomas from control [AUC (95% CI): CRCvscontrol 0.96 (0.89-1); AAvscontrol 0.96 (0.93-1); LAvscontrol 0.96 (0.92-0.99); SAvscontrol 0.96 (0.94-0.99)]. There were no significant differences between CRC and adenoma groups. Patients with adenomas and controls were discriminated prior to polypectomy, whereas 3 months after polypectomy VOC profiles were similar [T0 adenomavscontrol 0.98 (0.95-1); T1 adenomavscontrol 0.55 (0.40-0.69)]. Conclusions Faecal VOC profiles may be useful for early detection of CRC and adenomas and the timing of polyp surveillance as polypectomy led to a normalization of the VOC profile.
引用
收藏
页码:1119 / 1129
页数:11
相关论文
共 24 条
[1]   Exhaled volatile organic compounds identify patients with colorectal cancer [J].
Altomare, D. F. ;
Di Lena, M. ;
Porcelli, F. ;
Trizio, L. ;
Travaglio, E. ;
Tutino, M. ;
Dragonieri, S. ;
Memeo, V. ;
de Gennaro, G. .
BRITISH JOURNAL OF SURGERY, 2013, 100 (01) :144-151
[2]   Colorectal cancer [J].
Ballinger, Anne B. ;
Anggiansah, Clive .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7622) :715-718
[3]   Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer [J].
Bond, Ashley ;
Greenwood, Rosemary ;
Lewis, Stephen ;
Corfe, Bernard ;
Sarkar, Sanchoy ;
O'Toole, Paul ;
Rooney, Paul ;
Burkitt, Michael ;
Hold, Georgina ;
Probert, Chris .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (08) :1005-1012
[4]   Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry [J].
Boots, A. W. ;
Smolinska, A. ;
van Berkel, J. J. B. N. ;
Fijten, R. R. R. ;
Stobberingh, E. E. ;
Boumans, M. L. L. ;
Moonen, E. J. ;
Wouters, E. F. M. ;
Dallinga, J. W. ;
Van Schooten, F. J. .
JOURNAL OF BREATH RESEARCH, 2014, 8 (02)
[5]   The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose [J].
Bosch, Sofie ;
Lemmen, Jesse P. M. ;
Menezes, Renee ;
van der Hulst, Rene ;
Kuijvenhoven, Johan ;
Stokkers, Pieter C. F. ;
de Meiji, Tim G. J. ;
de Boer, Nanne K. H. .
JOURNAL OF BREATH RESEARCH, 2019, 13 (04)
[6]   Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study [J].
Cross, Amanda J. ;
Wooldrage, Kate ;
Robbins, Emma C. ;
Kralj-Hans, Ines ;
MacRae, Eilidh ;
Piggott, Carolyn ;
Stenson, Iain ;
Prendergast, Aaron ;
Patel, Bhavita ;
Pack, Kevin ;
Howe, Rosemary ;
Swart, Nicholas ;
Snowball, Julia ;
Duffy, Stephen W. ;
Morris, Stephen ;
von Wagner, Christian ;
Halloran, Stephen P. ;
Atkin, Wendy S. .
GUT, 2019, 68 (09) :1642-1652
[7]   Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study [J].
de Meij, Tim G. ;
Ben Larbi, Ilhame ;
van der Schee, Marc P. ;
Lentferink, Yvette E. ;
Paff, Tamara ;
Droste, Jochim S. Terhaar Sive ;
Mulder, Chris J. ;
van Bodegraven, Adriaan A. ;
de Boer, Nanne K. .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) :1132-1138
[8]  
Eiceman G.A., 2005, ION MOBILITY SPECTRO, DOI DOI 10.1201/9781420038972
[9]   Estimates of cancer incidence and mortality in Europe in 2008 [J].
Ferlay, J. ;
Parkin, D. M. ;
Steliarova-Foucher, E. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :765-781
[10]   Costs and Benefits of an Organized Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in the United States [J].
Guy, Gery P., Jr. ;
Richardson, Lisa C. ;
Pignone, Michael P. ;
Plescia, Marcus .
CANCER, 2014, 120 (15) :2308-2315